Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver replacement for alpha1-antitrypsin deficiency.

C W Putnam, K A Porter, R L Peters

    Surgery
    |March 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit.

    The American journal of gastroenterology·2001
    Same author

    Variation in the progression of diabetic nephropathy according to racial origin.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2001
    Same author

    Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection.

    Journal of viral hepatitis·2001
    Same author

    Acute hepatitis induced by bupropion.

    Digestive diseases and sciences·2000
    Same author

    Intrahepatic HCV levels in chronic HCV infection.

    Gut·1999
    Same author

    The contribution of inducible nitric oxide and cytomegalovirus to the stability of complex carotid plaque.

    Journal of vascular surgery·1999
    Same journal

    One-year health care expenditures and patient out-of-pocket spending after open versus minimally invasive hepatopancreatobiliary surgery.

    Surgery·2026
    Same journal

    Shock index, hypotension, and blood product transfusion as predictors of post-traumatic stress disorder in firearm-related trauma.

    Surgery·2026
    Same journal

    Outcomes following endovascular aortic aneurysm repair in nonagenarian patients.

    Surgery·2026
    Same journal

    Fistulotomy with primary sphincteroplasty for complex anal fistulas: Should we be concerned about incontinence?

    Surgery·2026
    Same journal

    No need for mesh in the repair of hiatal hernias: Autologous tissue hiatoplasty techniques for the repair of the complex diaphragmatic defect.

    Surgery·2026
    Same journal

    Incretin-based therapies and altered myocardial metabolism in a swine model of ischemic heart disease in the setting of metabolic syndrome.

    Surgery·2026
    See all related articles

    Liver transplantation can cure alpha-1-antitrypsin deficiency, a genetic liver disease. This study shows replacing the liver normalizes alpha-1-antitrypsin levels and phenotype, resolving the metabolic disorder.

    Area of Science:

    • Hepatology
    • Transplantation Immunology
    • Medical Genetics

    Background:

    • Alpha-1-antitrypsin deficiency (AATD) is an inherited disorder causing liver disease.
    • The homozygous Pi ZZ phenotype leads to severe AATD and cirrhosis.
    • Liver disease in AATD results from abnormal protein accumulation in hepatocytes.

    Purpose of the Study:

    • To evaluate the efficacy of orthotopic liver transplantation in treating severe AATD.
    • To determine if liver replacement corrects the metabolic defect of AATD.
    • To assess the long-term outcomes of liver grafts in AATD patients.

    Main Methods:

    • Orthotopic liver transplantation in a 16-year-old girl with advanced cirrhosis due to AATD.
    • Analysis of serum alpha-1-antitrypsin concentration and phenotype post-transplantation.

    Related Experiment Videos

  • Monitoring for graft rejection and protein deposition in liver homografts.

    • Main Results:

    • The first liver homograft (Pi MM phenotype) normalized serum AAT levels and phenotype.
    • The second homograft (Pi MZ phenotype) also resulted in a normal AAT phenotype.
    • Neither graft showed alpha-1-antitrypsin glycoprotein deposits, indicating metabolic cure.

    Conclusions:

    • Orthotopic liver transplantation effectively cures the hepatic manifestations of alpha-1-antitrypsin deficiency.
    • Liver replacement corrects the underlying metabolic defect, preventing harmful protein accumulation.
    • This demonstrates liver transplantation as a definitive treatment for severe AATD-related liver disease.